These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8597376)

  • 21. Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice.
    Baker MB; Podack ER; Levy RB
    Biol Blood Marrow Transplant; 1995 Dec; 1(2):69-73. PubMed ID: 9118294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.
    Blazar BR; Lees CJ; Martin PJ; Noelle RJ; Kwon B; Murphy W; Taylor PA
    J Immunol; 2000 Nov; 165(9):4901-9. PubMed ID: 11046015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fas and perforin cytotoxic pathways are not the major effector mechanisms in allogeneic resistance to bone marrow.
    Baker M; Podack ER; Levy RB
    Ann N Y Acad Sci; 1995 Dec; 770():368-9. PubMed ID: 8597377
    [No Abstract]   [Full Text] [Related]  

  • 24. Allo-major histocompatibility complex-restricted cytotoxic T lymphocytes engraft in bone marrow transplant recipients without causing graft-versus-host disease.
    Gao L; Yang TH; Tourdot S; Sadovnikova E; Hasserjian R; Stauss HJ
    Blood; 1999 Nov; 94(9):2999-3006. PubMed ID: 10556182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease.
    Merad M; Hoffmann P; Ranheim E; Slaymaker S; Manz MG; Lira SA; Charo I; Cook DN; Weissman IL; Strober S; Engleman EG
    Nat Med; 2004 May; 10(5):510-7. PubMed ID: 15098028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
    Austin Taylor M; Bennett M; Kumar V; Schatzle JD
    J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Veto activity of activated bone marrow does not require perforin and Fas ligand.
    Chrobak P; Gress RE
    Cell Immunol; 2001 Mar; 208(2):80-7. PubMed ID: 11333140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
    Williams FH; Thiele DL
    Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of cytotoxic T lymphocytes in corneal allograft rejection.
    Hegde S; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perforin-dependent cytolytic responses in beta2-microglobulin-deficient mice.
    Smyth MJ; Snook MB
    Cell Immunol; 1999 Aug; 196(1):51-9. PubMed ID: 10486155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation.
    Bergmann CC; Parra B; Hinton DR; Chandran R; Morrison M; Stohlman SA
    J Immunol; 2003 Mar; 170(6):3204-13. PubMed ID: 12626579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
    Medana I; Li Z; Flügel A; Tschopp J; Wekerle H; Neumann H
    J Immunol; 2001 Jul; 167(2):674-81. PubMed ID: 11441070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS; Engelhard VH
    J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity.
    Shustov A; Luzina I; Nguyen P; Papadimitriou JC; Handwerger B; Elkon KB; Via CS
    J Clin Invest; 2000 Sep; 106(6):R39-47. PubMed ID: 10995792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoids attenuate acute graft-versus-host disease by suppressing the cytotoxic capacity of CD8(+) T cells.
    Theiss-Suennemann J; Jörß K; Messmann JJ; Reichardt SD; Montes-Cobos E; Lühder F; Tuckermann JP; AWolff H; Dressel R; Gröne HJ; Strauß G; Reichardt HM
    J Pathol; 2015 Mar; 235(4):646-55. PubMed ID: 25358639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice.
    Johansson MH; Taylor MA; Jagodic M; Tus K; Schatzle JD; Wakeland EK; Bennett M
    J Immunol; 2006 Dec; 177(11):7923-9. PubMed ID: 17114464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice.
    Kägi D; Ledermann B; Bürki K; Seiler P; Odermatt B; Olsen KJ; Podack ER; Zinkernagel RM; Hengartner H
    Nature; 1994 May; 369(6475):31-7. PubMed ID: 8164737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.